Serum levels of soluble CD30 molecule (Ki‐1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage
- 1 June 1990
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 75 (2) , 282-284
- https://doi.org/10.1111/j.1365-2141.1990.00282.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Ki‐1 (CD30) antigen is released by Ki‐1‐positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki‐1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme‐linked immunosorbent assayEuropean Journal of Immunology, 1989
- Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification.Journal of Clinical Pathology, 1987
- Soluble interleukin-2 receptors in the serum of patients with Hodgkin's diseaseBritish Journal of Cancer, 1987
- The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cellsBlood, 1985
- The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cellsBlood, 1985
- Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cellsNature, 1982